维普期刊资源整合服务平台（V6.5）

46篇 您的检索式：作者名="ANTILA S"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Pharmacokinetics and pharma- codynamics of simendan, a novel calcium sensitizer,in healthy volunteers 显示文摘	Lilleberg J Antila S Karlsson M	1994	Clin Pharmacol Ther1994，56，：	1
2	Clinical pharmacology of levosimen- dan 显示文摘	Antila S Sundberg S Lehtonen LA	2007	Clinical Pharmacokinetics2007，46，7：	1
3	Studies on psychomotoric effects and pharmacokinetic interactions of the new calcium sensiti- zing drug levosimendan and ethanol 显示文摘	Antila S Jarvinen A Akkila J	1997	Areneim - Forsch/Drug Res1997，47，：	1
4	lntergrated pharmacokinet- ics and pharmacodynamics of the novel calcium sensitizer levosimen- dan as assessed by systolic time intervals 显示文摘	Sundberg S Antila S Scheinin H	1998	Int J Clin Pharmacol Ther1998，12，：	1
5	Pharmacokinetics and phar- macodynamics of intravenous inotropic agents 显示文摘	Lehtonen LA Antila S Pentikainen PJ	2004	Clin Pharmacoki- net2004，43，3：	1
6	Clinical pharmacology of levosimendan显示文摘	Antila S Sundberg S Lehtonen LA		0，，07：	1
7	Clinical pharmacology of levosimendan 显示文摘	Antila S Sundbcrg S Lehtonen LA	2007	Clin Pharmacokinet2007，46，7：	1
8	Pharmacokinet-ic and pharmacodynamic interaction between the novel calcium sensitiser levosimendan and warfarin 显示文摘	Antila S Jarvinen A Honkanen T	2000	Eur J Clin Pharmacol2000，56，910：	1
9	Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extendedlnfusion in Patients with Severe Heart Failure显示文摘	Kivikko M Antila S Eha J	2002	J Clin Pharmacol2002，42，1：	1
10	Pharmacokinetics andpharmacodynamics of intravenous inotropic agents 显示文摘	Lehtonen LA Antila S Pentikainen PJ	2004	Clin Pharm-acokinet2004，43，3：	1
11	Pharmacokineticsand pharmacodynamics of intravenous inotropic agents显示文摘	Lehtonen L A Antila S Pentik inen P J	2004	Clin Pharmacokinet2004，43，3：	1
12	Pharmacokinctics of Ievosimcndan and its mctabolites during and after a 24-hour continuous infusion in patients with severe heart failure显示文摘	Kivikko M Antila S Eha J ctal	2002	Int J Clin Pharmacoi Ther2002，40，10：	1
13	Pharmacokinetics and pharmaco- dynamics of intravenous inotropic agents 显示文摘	Lehtonen LA Antila S Pentikainen PJ	2004	Clin Pharmacokinet2004，43，3：	1
14	Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan显示文摘	Antila S Kivikko M Lehtonen L	2004	Br J Clin Pharmacol2004，57，：	1
15	Pharmacodynamics and safety of a new calcium sensitizer,levosimendan,and its metabolites during an extended infusion in patients with severe heart failure显示文摘	Kivikko M Antila S Eha J	2002	J Clin Pharmacol2002，42，：	1
16	Pharmacokinetics and pharmacodynamics of intravenous inotropic agents 显示文摘	Lehtonen LA Antila S Pentikainen PJ	2004	Clin Pharmaeokinet2004，43，3：	1
17	Pharmacokinetics and pharmacodynamics of intravenous inotropic agents显示文摘	Lehtonen LA Antila S Pentikainen PJ	2004	Clin Pharmacokinet2004，43，3：	1
18	Clinical pharma- cology oflevosimendan 显示文摘	Antila S Sundberg S Lehtonen LA	2007	Clin Pharmacokinet2007，46，7：	1
19	Evidence for variable selective pressures at MCIR显示文摘	Harding R M Healy E Ray A J Ellis N S Flanagan N Todd C Dixon C Sa]antila A Jackson I J Birch-Machin MA Rees J L	2000	Am J Hum Genet2000，66，：	1
20	Pharmacokinetics and pharmacodynamics of intravenous inotropic agents 显示文摘	LEHTONEN L A ANTILA S PENTIKAINEN P J	2004	Clin Pharmacokinet2004，43，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示